HomeFileStructural heart disease

Structural heart disease

Self-Expanding Valve vs. Balloon-Expandable Valve, Randomized, Head to Head

The “arms race”among transcatheter valves has been vertiginous. By the time we received the mid- or long-term...

Estimating the Risk of Infection for Healthcare Personnel

Roughly one out of every 100 healthcare workers at hospitals receiving COVID-19 patients become infected. Statistics are not...

Frailty and Bleeding: Impact on Aortic Valve Replacement

Courtesy of Dr. Carlos Fava. We are well aware that both transcatheter aortic valve replacement (TAVR) and surgical...

Leaflet Thickening and Immobility in Evolut Low Risk

Leaflet thickening and immobility caused by thrombosis have been reported for both surgical and transcatheter bioprostheses. This phenomenon...

TAVR: Balloon-Expandable or Self-Expanding Valves, Which Is the Answer?

Courtesy of Dr. Carlos Fava. Transcatheter aortic valve replacement (TAVR) has shown benefit and is currently moving towards low-risk...

Should We Finalize TAVR with Atrial Pacing in Some Patients?

Courtesy of Dr. Carlos Fava. The benefits of transcatheter aortic valve replacement (TAVR) are undoubtedly clear, but implantation is...

Malignancies and Aortic Stenosis: Is TAVR Warranted?

This meta-analysis tells us that patients with active malignancies and severe aortic stenosis have a good evolution...

Webinar SOLACI – 27/05 – Up-To-Date-TAVR: Evidence, Durability and Challenging Anatomies

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be...